Equities

Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc

Actions
  • Price (USD)8.81
  • Today's Change0.10 / 1.15%
  • Shares traded919.53k
  • 1 Year change+103.94%
  • Beta1.1818
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,3942,2122,094
OPERATING EXPENSES
Cost of revenue total1,5371,4161,302
Selling, general and admin. expenses, total434404373
Depreciation/amortization------
Unusual expense(income)7029464
Other operating expenses, total(16)(3.23)0.20
Total operating expense2,1892,3071,941
Operating income204(95)153
Other, net(36)1815
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(40)(248)31
Provision for income taxes8.456.6611
Net income after taxes(49)(255)20
Minority interest(35)125(9.55)
Net income before extra. Items(84)(130)11
Total extraordinary items------
Net income(84)(130)11
Inc.avail. to common excl. extra. Items(84)(130)11
Inc.avail. to common incl. extra. Items(84)(130)11
EPS RECONCILIATION
Basic/primary weighted average shares176151149
Basic/primary eps excl. extra items(0.48)(0.86)0.07
Basic/primary eps incl. extra items(0.48)(0.86)0.07
Dilution adjustment------
Diluted weighted average shares176151152
Diluted eps excl. extra items(0.48)(0.86)0.07
Diluted eps incl. extra items(0.48)(0.86)0.07
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental211158136
SUPPLEMENTAL INCOME
Depreciation, supplemental717361
Total special items7029464
NORMALISED INCOME
Normalized income before taxes304695
Effect of special items on income taxes2510323
Income tax excluding impact of special items3311034
Normalized income after tax(2.91)(64)61
Normalized income avail. to common(38)6151
Basic normalized EPS(0.22)0.410.35
Diluted normalized EPS(0.22)0.410.34
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.